4.7 Article

The extracellular matrix landscape in salivary gland carcinomas is defined by cellular differentiation via expression of three distinct protein modules

期刊

JOURNAL OF PATHOLOGY
卷 260, 期 2, 页码 148-164

出版社

WILEY
DOI: 10.1002/path.6071

关键词

salivary gland carcinomas; extracellular matrix; machine learning; network analysis; mass spectrometry (LC-MS); proteomics; tumor microenvironment; bioinformatics; differential expression; clustering analysis

向作者/读者索取更多资源

This study characterized the extracellular matrix (ECM) landscape of salivary gland carcinomas (SGCs) and identified two fundamental SGC ECM classes. Three biologically distinct protein modules associated with ECM were described, and their differential expression across ECM classes and cell types had a prognostic impact on different SGC types. Putative therapeutic targets for SGC were also identified based on the proteomic expression profile.
The extracellular matrix (ECM) is an integral part of the tumor microenvironment of carcinomas. Even though salivary gland carcinomas (SGCs) display a range of tumor cell differentiation and distinct extracellular matrices, their ECM landscape has not been characterized in depth. The ECM composition of 89 SGC primaries, 14 metastases, and 25 normal salivary gland tissues was assessed using deep proteomic profiling. Machine learning algorithms and network analysis were used to detect tumor groups and protein modules that explain specific ECM landscapes. Multimodal in situ studies to validate exploratory findings and to infer a putative cellular origin of ECM components were applied. We revealed two fundamental SGC ECM classes which align with the presence or absence of myoepithelial tumor differentiation. We describe the SGC ECM through three biologically distinct protein modules that are differentially expressed across ECM classes and cell types. The modules have a distinct prognostic impact on different SGC types. Since targeted therapy is rarely available for SGC, we used the proteomic expression profile to identify putative therapeutic targets. In summary, we provide the first extensive inventory of ECM components in SGC, a difficult-to-treat disease that encompasses tumors with distinct cellular differentiation. (c) 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据